[Construction of a highly efficient HBV infection cell model based on HBV co-receptor neuropilin-1] [0.03%]
基于HBV辅助受体神经纤毛蛋白-1建立高效HBV细胞感染模型
Z H Liu,X M He,K X Xu et al.
Z H Liu et al.
Objective: To construct a lentiviral plasmid expressing neuropilin-1 (NRP1) and a HepG2-sodium taurocholate cotransporting polypeptide (NTCP) capable of overexpressing stable cell line NRP1 so as to study the susceptibility of this cell lin...
[Analysis of antiviral efficacy in pediatric patients with HBeAg-negative chronic hepatitis B] [0.03%]
乙型肝炎e抗原阴性慢性乙肝患儿的抗病毒疗效分析
X Guo,P Y Fan,J Li et al.
X Guo et al.
Objective: To analyze the antiviral efficacy and its influencing factors in pediatric patients with hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB). Methods: Thirty-eight initially treated pediatric patients with HBeAg-nega...
[Clinical research and medical ethics in the era of artificial intelligence] [0.03%]
人工智能时代临床研究与医学伦理学的发展
X Song,N Gao,K Q Huang et al.
X Song et al.
Artificial intelligence (AI), a core technology of the Fourth Industrial Revolution, profoundly reshapes the landscape of modern medicine. AI can extract information from extensive datasets, optimizing trial design, and enhancing research e...
[Research progress and future prospects for artificial intelligence in the diagnosis and treatment of fatty liver disease] [0.03%]
人工智能脂肪肝诊疗研究进展与未来展望
Y Y Lin,F Liu,H Y Rao
Y Y Lin
The continuous advancement of artificial intelligence (AI)-related technologies is promoting a diagnosis and treatment model for fatty liver disease toward precision medicine. AI assistance reduces human error and enhances the accuracy of n...
[Diagnosis and treatment of liver diseases in the era of artificial intelligence] [0.03%]
人工智能时代的肝病诊断与治疗
L Y Ren,D B Chen,H S Chen
L Y Ren
Artificial intelligence (AI) has shown great potential in the field of hepatology, and it is gradually revolutionizing novel research for liver diseases. However, its full integration into real-world diagnostic and treatment processes still...
[Analysis of the prevalence status and clinical characteristics of the hepatitis D virus in the Xinjiang region] [0.03%]
新疆地区乙肝病毒感染者丁肝病毒流行状况及临床特征分析
Z G Wang,X Wu,J Dou et al.
Z G Wang et al.
Objective: To investigate the prevalence status and the clinical characteristics of hepatitis D virus (HDV) among patients chronically infected with hepatitis B virus (HBV) in the Xinjiang region. Methods: A cross-sectional study was conduc...
[A review of research progress in integrated traditional Chinese and Western Medicine for liver diseases] [0.03%]
中西医结合治疗肝病的研究进展探讨
Q Zhang,B Tian,C Shan et al.
Q Zhang et al.
Liver disease is a major global health issue, severely impacting patients' quality of life and life expectancy. Integrated Traditional Chinese and Western Medicine demonstrates unique advantages in the field of liver disease treatment. Ther...
[Current research progress status in identifying hepatocellular ballooning degeneration in nonalcoholic steatohepatitis] [0.03%]
[非酒精性脂肪肝病肝细胞气球样变识别的现状与进展]
H R Xie,L Wei
H R Xie
Nonalcoholic steatohepatitis (NASH) is a chronic liver disease associated with metabolic syndrome, such as obesity, diabetes, and hyperlipidemia, and is a progressive form of nonalcoholic fatty liver disease with pathological features inclu...
H L Weng
H L Weng
Massive hepatic necrosis (MHN) is defined as hepatocyte death exceeding 70% in the entire liver. Acute liver failure induced by MHN can lead to death in nearly half of patients. However, the vast majority of lost hepatocyte conditions can r...
R L Zhang,C Y Chen,L Huang et al.
R L Zhang et al.
Portal hypertensive biliopathy is a secondary condition of intrahepatic and extrahepatic bile duct abnormalities caused by portal hypertension, especially in extrahepatic portal venous obstruction. Most patients may remain asymptomatic for ...